Physician profile
Michael Temple
NPI 1942930813
$1,678.91
in general payments reported to CMS, 2019-2025
13 companies · $736 in 2025
The $736 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $256 · 2024: $568 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $702.65 | 2022-2024 | Xarelto |
| Abbvie INC. | $176.72 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $148.91 | 2025 | Tremfya |
| Novo Nordisk INC | $145.30 | 2025 | Ozempic, Wegovy |
| Janssen Biotech, INC. | $142.33 | 2025 | Tremfya |
| Lilly USA, LLC | $133.66 | 2024-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $109.54 | 2025 | Entyvio |
| Orphalan INC | $27.34 | 2025 | Cuvrior |
| Travere Therapeutics, INC. | $24.72 | 2023 | |
| Melinta Therapeutics, LLC | $19.85 | 2022 | |
| Pfizer INC. | $18.35 | 2024 | |
| Intercept Pharmaceuticals, INC. | $14.93 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.61 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Temple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.